6 - Alcoholic and Nonalcoholic Fatty Liver Disease Flashcards

1
Q

Primary place of lipid metabolism

A

Liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What leads to fatty changes?

A

“Stressors”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two categories of Fatty Liver?

A

Alcoholic

Non-Alcoholic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Secondary Steatosis - Fatty Liver

A

Alcohol
Overnutrition (Obesity, metabolic syndrome)
Starvation
TPN (Total parenteral nutrition)
Drugs (Amiodarone, methotrexate, tamoxifen, steroids)
Infections (HIV, HCV)
Celiac Disease
Genetic Causes (Abetalipoproteinemia, Wilson’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Alcohol-Induced Steatosis

A

(+/-)Alcoholic Hepatitis
Fibrosis
Cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Non-Alcohol-Induced Steatosis

A

(+/-)Non-alcoholic Steatohepatitis
Fibrosis
Cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Spectrum of Alcoholic Liver Disease

A

Alcoholic Fatty Liver Disease
Fibrosis
Alcoholic Hepatitis
Cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cutoff for how much fat the liver can handle as “normal”

A

5% of volume as fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CDC definition of “moderate drinking”

A

2 drinks per day for men

1 drink per day for women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Risk factors for ALD

A

Amount of alcohol ingested:
Non-linear
Drinking outside of mealtime increases risk by 2.7 fold
Syngergistic relationship between viral hepatitis and alcohol in terms of advancing liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How many grams in a standard drink?

A

12oz beer
8oz malt liquor
5oz wine
1.5oz distilled spirits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risk of cirrhosis increases (men)

A

> 60 - 80g/day for at least 10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Risk of cirrhosis increases (women)

A

> 20g/day for at least 10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CAGE Criteria

A

Tried to CUT down
People ANNOYED you by criticizing drinking
Felt GUILTY about drinking
Needed an EYE OPENER

Score of 2 is clinically significant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Damage done in alcoholic hepatitis

A

NAD accepts proton from alcohol dehydrogenase
Forms acetaldehyde
Free-reactive species of acetaldehyde forms adducts
Increases ROS formation
Increases NADH/NAD+ ratio

Acetaldehyde build up causes majority of damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CYP2E1 Pathway in Alcohol Metabolism

A

ROS species increases
Outbalances reduction
Inflammation ensues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

LPS’s Role in Alcohol-Induced Liver Injury

A

Ethanol promotes translocation of LPS
Lumen of small intestine to Portal vein to liver

In Kupffer cell, LPS stimulates activation through promotion of cytokine and ROS release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Alcoholic Hepatitis

A

Clinical syndrome of acute jaundice and liver failure
Occurs after DECADES of alcohol abuse
Inflammatory
Fibrosis MAYBE but generally not cirrhotic

Scariest consequence:
Portal hypertension (due to microvascular occlusion secondary to hepatic swelling)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Alcoholic Hepatitis - Presentation

A
Rapid onset of jaundice
Fever
Ascites
Proximal muscle loss
Encephalopathy
Liver is enlarged & tender
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Alcoholic Hepatitis - Physical Exam

A

Signs of Chronic Alcohol Use:
Parotid enlargement
Dupuytren’s Contracture
Gynecomastia (relative depletion of testosterone)

Signs of Severe Liver Disease:
Visible veins across the abdominal wall
Edema
Ascites
Spider telangiectasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Alcoholic Hepatitis - Histo

A

Ballooned Hepatocytes
Mallory bodies (alcoholic hyaline) surrounded by PMNs
Amorphous eosinophilic inclusion bodies
Large fat globules (macro-steatosis) in hepatocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Alcoholic Hepatitis - Labs

A

Elevation of serum aminotransferases (hallmark of hepatitis)
AST/ALT ratio > 2

Maddrey Discriminant Function:
Poor prognosis >= 32 (very high risk of dying, 30 - 50 % 28 day mortality)

Lille Model:
Helps predict mortality to guide therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Alcoholic Hepatitis - Treatment

A

Abstinence (though risk of progressing to cirrhosis remains)
Treat nutritional deficiencies

Steroids (1st line):
Prednisolone 40 mg/day for one month, then discontinue or taper over 3w
Appropes for those with MDF >= 32
15 - 30% risk reduction in short term (28d) mortality in early studies, 4% in more recent studies

24
Q

Alcoholic Hepatitis - Other treatments

A

Anti-cytokine therapy:
Mitigates the effects of dysregulatd cytokines (TNF-α)

Pentoxifylline:
Inhibits production of TNF-α and other cytokines
STOPAH trial showed NO mortality benefit

25
Q

Transplantation and CIrrhosis

A

Longstanding alcohol use and/or alcoholic hepatitis leads to fibrosis/cirrhosis

Alcoholic hepatitis and active drinking are absolute contraindications to consideration for liver transplantation

Require at least 6 months abstinence from drinking prior to transplant evaluation

26
Q

Nonalcoholic Fatty Liver Disease

A

Entire spectrum of fatty liver disease without significant alcohol use, ranges from fatty liver to steatohepatitis to cirrhosis

27
Q

Nonalcoholic Fatty Liver (NAFL)

A

Hepatic steatosis
No evidence of hepatocellular injury (ballooning)
No fibrosis

28
Q

Nonalcoholic Steatohepatitis (NASH)

A

Hepatic steatosis
Inflammation
Hepatocyte injury (ballooning)
(+/-) fibrosis

29
Q

NASH Cirrhosis

A

Cirrhosis

Previous histological evidence of steatosis or steatohepatitis

30
Q

Metabolic Syndrome - Definition

A

Abdominal obesity
Hypertension
Diabetes
Dyslipidemia

31
Q

Metabolic Syndrome - Associated wtih

A

Impaired glucose metabolism
Impaired fatty acid utilization
Dyslipidemia

32
Q

Metabolic Syndrome and NASH

A

Present in 88% with NASH

54% with NAFLD without NASH

33
Q

Metabolic Syndrome - Hepatic Manifestation Venn Diagram

A

Insulin Resistance
Obesity
Hyperlipidemia

34
Q

How many American Adults are overweight (BMI>25)

A

2/3

35
Q

From 1960 - 2000 What happened to obesity prevalence?

A

DOUBLED

36
Q

Cost of obesity epidemic

A

$117 billion

37
Q

NAFLD - Epidemiology

A

Most common liver diseases in Western, industrialized countries
20 - 40% of general population
More common in men
Majority of cases occur in men between 40 and 60
Hispanics > Caucasians > African Americans

38
Q

NASH - Two Hit Pathogenesis

A

First Hit:
Fat accumulation
Discrepancy between influx/synthesis of hepatic lipids and β-oxidation and export leading to buildup of triglycerides

Second Hit:
Oxidative stress
Lipid peroxidation
Release of cytokines (TNF-α)
Adipocyte derived hormones
39
Q

Main driver for fibrosis

A

Insulin resistance

Leads to cytokines, inflammatory signaling, stellate cell activation, apoptosis, mitochondrial injury, oxidative stress, etc

40
Q

NAFLD Pathology

A

Macrovesicular steatosis
Hepatocyte balooning
Lobular inflammation (Mixed leukocytes)
Mallory bodies (eosinophilic inclusions)

Perivenular & sinusoidal fibrosis - Scarring around central vein
(NOT PRESENT IN ALCOHOLIC)

41
Q

Presentation

A

Asymptomatic - Normal Liver Chemistries
Elevated transaminases
Fibrosis
Cirrhosis

42
Q

Picture of Pediatric Fatty Liver

A

Hepatic steatosis
Portal & lobular inflammation

Improper nutrition
Cardiometabolic risk
Lipid associated (leptin resistance, visceral obesity, etc)

43
Q

NAFLD Comorbidities

A
Obesity
Type 2 DM
Glucose Intolerance
Dyslipidemia
Metabolic Syndrome
OSA
Hypothyroid
Hypopituitary
PCOS
Hypogonad
44
Q

NAFLD Diagnosis

A

AST & ALT elevation (90% of patients)

AST/ALT:
1 in ASH

No study outside of biopsy can differentiate between simple steatosis & NASH

45
Q

NAFLD Progression

A

Progression from Stage 0 to Stage 4

NAFLD (100%)
Fibrosis Progression (33%)
Rapid Fibrosis Progression (20%)

Annual fibrosis progression rate

  1. 07 stages for NAFL
  2. 14 stages for NASH
46
Q

NASH and End Stage Liver Disease

A

Prevalence of cirrhosis ranges from 3 - 15%
Once cirrhosis sets in, nothing can reverse it
Only cure for decompensated cirrhosis is transplant

47
Q

Histologically learn to tell the difference between

A

Fatty Liver
NASH
NASH with Fibrosis
Cirrhosis

48
Q

How do we diagnose NASH?

A

LIVER BIOPSY

49
Q

NASH vs ASH

A

38 - 50% of patients with ASH progress to cirrhosis (7 years)

8 - 26% of NASH patients progress to cirrhosis

Lower survival rates in ASH:
5 year (38% vs. 67% in NASH)
10 year (15% vs. 59% in NASH)
50
Q

NASH & Cirrhosis

A

Prevalence of obesity increased among cryptogenic cirrhotics

DM prevalence high with cirrhosis

51
Q

How many projected patients have NASH?

A

25 million

52
Q

How many transplants were performed for NASH in 2002

A

160

53
Q

Treatment of NAFLD

A

Mainstay - Lifestyle Intervention:
Diet
Behavior modification
Physical activity (Exercise reduces steatosis even without weight loss)

Weight loss:
Medical
Surgical

54
Q

Pharmacotherapy

A
Insulin Sensitizers
PPAR-α/δ agonists
FXR agonists
Antioxidants
Caspase Inhibitors
Antifibrotics
55
Q

Current Recommendations - Biopsy proven NASH, nondiabetic, noncirrhotic

A

Vitamin E 800 IU/d

56
Q

Current Recommendations - Biopsy proven NASH, diabetic

A

Pioglitazone (Safety data in NASH limited)

57
Q

Current Recommendations - NAFLD + Hypertriglyceridemia

A

Omega-3 Fatty Acids